BioHealth News Archive

UM Ventures-Backed Breethe Acquired by Abiomed – University of Maryland, Baltimore

UM Ventures-Backed Breethe Acquired by Abiomed – University of Maryland, Baltimore

Last week, Abiomed acquired Baltimore-based startup Breethe for its innovative respiratory device. Breethe is a startup out of the University of Maryland, Baltimore (UMB) that…

Read More
Biobuzz Directory – Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage

Biobuzz Directory – Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage

Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans COLUMBIA, Md., May 4, 2020 Intralytix, Inc. announced today that…

Read More
Start-up hits $1 billion virtually as virus shifts Silicon Valley riches

Start-up hits $1 billion virtually as virus shifts Silicon Valley riches

When VAST Data hit the hallmark of this era’s Silicon Valley start-up boom last month, a $1 billion so-called unicorn valuation, it didn’t come…

Read More
The top pharma companies in social media | FiercePharma

The top pharma companies in social media | FiercePharma

Social media is no longer just a numbers game for pharma companies. Counting followers, tallying likes or tracking shares was a good start, but…

Read More
Emergent Biosolutions CEO: No ‘guarantee’ vaccine will be ready this year

Emergent Biosolutions CEO: No ‘guarantee’ vaccine will be ready this year

Emergent Biosolutions CEO Robert Kramer told CNBC Monday it is uncertain that a coronavirus vaccine can be available by the end of the year to fulfill…

Read More
Immunomic Therapeutics Announces Appointments to its Board of Directors | Business & Finance | tullahomanews.com

Immunomic Therapeutics Announces Appointments to its Board of Directors | Business & Finance | tullahomanews.com

ROCKVILLE, Md.--(BUSINESS WIRE)--May 5, 2020-- Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today…

Read More
The SBA’s PPP: How to Prepare for a Potential Audit

The SBA’s PPP: How to Prepare for a Potential Audit

Since the enactment of the CARES Act, the Small Business Administration and U.S. Department of the Treasury have continually updated the rules governing the…

Read More
BioHealth Innovation Entrepreneur-in-Residence Feedback Session – May 27th

BioHealth Innovation Entrepreneur-in-Residence Feedback Session – May 27th

Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan?  Sign up by…

Read More
Immunomic Therapeutics Founder and CEO Bill Hearl RETURNS to BioTalk after completing a new $61.3 million raise.

Immunomic Therapeutics Founder and CEO Bill Hearl RETURNS to BioTalk after completing a new $61.3 million raise.

He joins BioTalk host Rich Bendis to discuss their recent successes in funding, research, and their growth in the BioHealth Capital Region Dr. William…

Read More
THE BIOHEALTH CAPITAL REGION (BHCR) IS CRITICAL TO AMERICA AND THE WORLD IN SOLVING HEALTHCARE’S CHALLENGES

THE BIOHEALTH CAPITAL REGION (BHCR) IS CRITICAL TO AMERICA AND THE WORLD IN SOLVING HEALTHCARE’S CHALLENGES

Today we hear phrases such as “In these difficult times” to highlight the challenges of the world with COVID-19 which is on all of…

Read More
Venture vs. The Virus: The Life Science/Healthcare Outlook for Fundraising During a Pandemic · BioBuzz (May 13)

Venture vs. The Virus: The Life Science/Healthcare Outlook for Fundraising During a Pandemic · BioBuzz (May 13)

I know what you’re thinking…it’s hard enough to raise venture capital for life science/healthcare startups in normal times, but throw a global pandemic and…

Read More
Venture vs. The Virus: The Life Science/Healthcare Outlook for Fundraising During a Pandemic · BioBuzz (May 13)

Venture vs. The Virus: The Life Science/Healthcare Outlook for Fundraising During a Pandemic · BioBuzz (May 13)

I know what you’re thinking…it’s hard enough to raise venture capital for life science/healthcare startups in normal times, but throw a global pandemic and…

Read More
UMB-born medical device company Breethe acquired by Abiomed – Technical.ly Baltimore

UMB-born medical device company Breethe acquired by Abiomed – Technical.ly Baltimore

Breethe, the medical device company founded by renowned University of Maryland School of Medicine surgeon and professor Dr. Bartley Griffith, has been acquired by…

Read More
Resources to Accelerate COVID Funding Applications

Resources to Accelerate COVID Funding Applications

Are you working with a technology that may be valuable to the fight against COVID-19?  BHI has expanded its federal funding assistance program to…

Read More
“Bayh-Dole 40 and the Coronavirus Crisis” Video Webinar RECAP (Webinar occurred on 4/23)

“Bayh-Dole 40 and the Coronavirus Crisis” Video Webinar RECAP (Webinar occurred on 4/23)

On April 23, 2020, the Bayh-Dole 40 Coalition and the Information Technology and Innovation Foundation co-hosted a video webinar on the critical role that…

Read More